Kanako Ichikura

Dr. Kanako Ichikura

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 January 2022 in Journal of Psychosomatic Research
Verified
Journal Article
Open access
YFYuko Fukase
Yuko Fukase
KIKanako Ichikura
Kanako Ichikura
HMHanako Murase
Hanako Murase
HTHirokuni Tagaya
Hirokuni Tagaya
The coronavirus 2019 (COVID-19) pandemic has particularly influenced the mental health of younger adults; accordingly, this study investigated age-related factors related to mental health and provided suggestions related to mental health recovery. A web-based longitudinal survey was conducted from 2020 to 2021 in Japan. The survey consisted of the Patient Health Questionnaire-9 (PHQ-9), used to measure depressive symptoms as a response variable, and an anger questionnaire and coping strategy scale to assess explanatory variables. A total of 1468 participants were analyzed (valid response rate = 54.2%); 368 were younger adults (age range = 20–39), 667 were middle-aged adults (age range = 40–64), and 433 were aged adults (age range = 65–79). The PHQ-9 scores in the younger adults worsened over the three survey timepoints. State anger was strongly related to PHQ-9 scores in all age groups (standardized beta = 0.39–0.47), and state anger in the younger group was highest at all survey times, In the younger group, only nonadaptive coping strategies were related to PHQ-9 scores. Emotional support, venting, and humor adaptive strategies used by middle-aged and aged adults were most commonly used by younger adults; however, there were no significant relationships of these strategies with PHQ-9 scores in the younger group. The level of depressive symptoms among the younger adults might be considerably worse than the middle-aged and aged adult. The younger adults might not make use of strategies, hence, they might need advice and skill training of strategies.

2 January 2020 in Esophagus
Verified
Journal Article
Closed access
PDF file
YOYu Ohkura
Yu Ohkura
KIKanako Ichikura
Kanako Ichikura
JSJunichi Shindoh
Junichi Shindoh
MUMasaki Ueno
Masaki Ueno
HUHarushi Udagawa
Harushi Udagawa
EMEisuke Matsushima
Eisuke Matsushima

19 June 2015 in Palliative and Supportive Care
Verified
Journal Article
Closed access
PDF file
KIKanako Ichikura
Kanako Ichikura
AYAya Yamashita
Aya Yamashita
TSTaro Sugimoto
Taro Sugimoto
SKSeiji Kishimoto
Seiji Kishimoto
EMEisuke Matsushima
Eisuke Matsushima
Objective: Many patients with head and neck cancer (HNC) suffer from psychological distress associated with dysfunction and/or disfigurement. Our aim was to evaluate the ratio of patients with persistence of psychological distress during hospitalization and identify the predictors of persistence or change in psychological distress among HNC patients.Method: We conducted a single-center longitudinal study with self-completed questionnaires. We evaluated psychological distress (the Hospital Anxiety and Depression Scale; HADS) and functional level (the Functional Assessment of Cancer Therapy–Head and Neck Scale; FACT–H&N) among patients during hospitalization at the Medical Hospital of Tokyo Medical and Dental University.Results: Of 160 patients, 117 (73.1%) completed the questionnaire at both admission and discharge. Some 42 (52.5%) patients reported persistent psychological distress. The physical well-being of patients with continued distress was significantly lower than that of other patients (21.7 ± 4.7, 19.4 ± 6.1, 19.5 ± 5.4;p< 0.01), and the emotional well-being of patients with continued distress was significantly lower than that in patients with no distress and reduced distress (22.3 ± 3.5, 20.5 ± 2.5; p < 0.01).Significant of results: Impaired physical and emotional function appears to be associated with persistent psychological distress among HNC patients. Psychological interventions focused on relaxation, cognition, or behavior may be efficacious in preventing such persistent distress.

1 January 2017 in International Journal of Clinical and Health Psychology
Verified
Journal Article
Open access
KIKanako Ichikura
Kanako Ichikura
SKSayaka Kobayashi
Sayaka Kobayashi
SMShiho Matsuoka
Shiho Matsuoka
TSTsuyoshi Suzuki
Tsuyoshi Suzuki
KNKatsuji Nishimura
Katsuji Nishimura
SSShin-Ichi Suzuki
Shin-Ichi Suzuki
Objective: Many patients with implantable cardioverter defibrillators experience depressive symptoms. In addition, avoidance behavior is a common problem among patients with implantable cardioverter defibrillators. We examined the association between avoidance behaviors and depressive symptoms in patients with implantable cardioverter defibrillators. Method: We conducted a single-center, cross-sectional study with self-completed questionnaires between May 2010 and March 2011. We measured avoidance behaviors (avoidance of places, avoidance of objects, and avoidance of situations) and depressive symptoms (using the Beck Depression Inventory, Version II) in 119 participants. An avoidance behaviors instrument was developed for this study and we confirmed its internal consistency reliability. Results: Ninety-two (77.3%) patients were aged older than 50 years, and 86 (72.3%) were men. Fifty-one (42.9%) patients reported "avoidance of places", 34 (28.6%) reported "avoidance of objects", and 63 (52.9%) reported "avoidance of activity". Avoidance behavior was associated with increased odds for the presence of depressive symptoms (OR 1.31; 95% CI 1.06-1.62). Conclusions: This was the first study to identify the relationship between avoidance behavior and depressive symptoms among patients with implantable cardioverter defibrillators; however, there are a few methodological limitations.

1 September 2020 in International Journal of Clinical and Health Psychology
Verified
Journal Article
Open access
KIKanako Ichikura
Kanako Ichikura
NNNao Nakayama
Nao Nakayama
SMShiho Matsuoka
Shiho Matsuoka
YAYosuke Ariizumi
Yosuke Ariizumi
TSTakuro Sumi
Takuro Sumi
EMEisuke Matsushima
Eisuke Matsushima
Patients with head and neck cancer (HNC) have some problems such as dysfunction of breathing, eating, and/or speaking. The aim of this study was to examine efficacy of the stress management program for HNC patients (SMAP-HNC) compared with usual care (UC). We conducted a pilot study of SMAP-HNC for depressive HNC patients between January 2016 and March 2018. The program contains psychoeducation, stress coping training, and operant reinforcement. The outcome measure was the Hospital Anxiety and Depression Scale (HADS), Functional Assessment of Cancer Therapy (FACT), and Brief Coping Inventory (COPE). Twenty patients were randomly assigned to SMAP-HNC and UC group. Although a small sample sizes, there was no significant difference of depression score change between SMAP-HNC and UC group (Hedges’d g -0.83; 95% CI -1.80 to 0.13). It was the first study to conduct stress management program for HNC patients. Unfortunately, our trial designed as a randomized controlled trial is underpowered to make conclusion as to the efficacy of SMAP-HNC. However, there are some valuable suggestions to modify the stress management program in future.

31 August 2017 in Psycho-Oncology
Verified
Journal Article
Closed access
PDF file
KIKanako Ichikura
Kanako Ichikura
AYAya Yamashita
Aya Yamashita
TSTaro Sugimoto
Taro Sugimoto
SKSeiji Kishimoto
Seiji Kishimoto
EMEisuke Matsushima
Eisuke Matsushima